Clinical Trial Update: Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing adjuvant chemotherapy regimens for stage II/III rectal cancer; results completed and posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer
• Rectal Mucinous Adenocarcinoma
• Rectal Signet Ring Cell Adenocarcinoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma | Phase 3 | Status: COMPLETED | Results posted: 2018-12-04